Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet 2017; 389:1941-1952

Article  PubMed  Google Scholar 

Ley B, Collard HR, King TE, Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183:431-440

Article  PubMed  Google Scholar 

Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824

Article  PubMed  PubMed Central  Google Scholar 

Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis. Respir Med 2015; 109:661-670

Article  PubMed  Google Scholar 

Gleeson F, Fraser E. Hyperpolarized Xenon MRI, Further Evidence of Its Use in Progressive Pulmonary Fibrosis? Radiology 2022; 305:697-698

Article  PubMed  Google Scholar 

Hunninghake GM. A new hope for idiopathic pulmonary fibrosis. N Engl J Med 2014; 370:2142-2143

Article  CAS  PubMed  Google Scholar 

Nathan SD, Meyer KC. IPF clinical trial design and endpoints. Curr Opin Pulm Med 2014; 20:463-471

Article  PubMed  PubMed Central  Google Scholar 

Wu X, Kim GH, Salisbury ML, et al. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med 2019; 199:12–21

Sullivan DC, Obuchowski NA, Kessler LG, et al. Metrology Standards for Quantitative Imaging Biomarkers. Radiology 2015; 277:813-825

Article  PubMed  Google Scholar 

Raghu G, Collard HR, Anstrom KJ, et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2012; 185:1044-1048

Article  PubMed  PubMed Central  Google Scholar 

Nathan SD, Shlobin OA, Weir N, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011; 140:221-229

Article  PubMed  Google Scholar 

Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156:684-691

Article  PubMed  Google Scholar 

Kusmirek JE, Martin MD, Kanne JP. Imaging of Idiopathic Pulmonary Fibrosis. Radiol Clin North Am 2016; 54:997-1014

Article  PubMed  Google Scholar 

Martin MD, Chung JH, Kanne JP. Idiopathic Pulmonary Fibrosis. J Thorac Imaging 2016; 31:127-139

Article  PubMed  Google Scholar 

Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198:e44-e68

Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME. Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 2019; 213:77-89

Article  PubMed  Google Scholar 

Smith A, Varney E, Zand K, et al. Precision analysis of a quantitative CT liver surface nodularity score. Abdom Radiol (NY) 2018; 43:3307-3316

Article  PubMed  Google Scholar 

Elkassem AA, Allen BC, Lirette ST, et al. Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C. AJR Am J Roentgenol 2021;

Pleasants R, Tighe RM. Management of Idiopathic Pulmonary Fibrosis. Ann Pharmacother 2019; 53:1238-1248

Article  PubMed  PubMed Central  Google Scholar 

Chen A, Karwoski RA, Gierada DS, Bartholmai BJ, Koo CW. Quantitative CT Analysis of Diffuse Lung Disease. Radiographics 2020; 40:28-43

Article  PubMed  Google Scholar 

Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012; 21:355-361

Article  PubMed  PubMed Central  Google Scholar 

King TE, Jr., Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378:1949-1961

Article  PubMed  Google Scholar